Novartis-Regulus Therapeutics gets US antitrust approval
MLex Summary: Novartis and Regulus Therapeutics have received antitrust clearance from the US authorities to close their $1.7 billion deal. Extract. ...To view the full article, register now.
Already a subscriber? Click here to view full article